论文部分内容阅读
本院于1973年初～1975年初,两年内应用广东省医药工业研究所提供的羟基脲共治白血病26例,真性红细胞增多症1例。现将治疗结果介绍如下。一、材料与方法(一)病例(全部住院病例)1.慢性粒细胞型白血病(慢粒)11例,女性6例,男性5例;年龄19～56岁10例,1岁1例。属于初次确诊,首次接受抗白血病药物治疗者4例,其余7例均曾接受马利兰或其他抗白血病药物治疗。2.慢性粒细胞型白血病急性变(慢粒急变)6例,女性1例,男性5例,年龄15～46岁,各例均多次接受马利兰治疗。3.急性粒细胞型白血病(急粒)4例,女性1例,男性3例,年龄19～22岁。4.急性单核细胞型白血病(急单)3例,全部男性,年龄26～49岁。5.急性淋巴细胞型白血病(急淋)2例,男性及女性各1例,年龄分别为23及47岁。6.真性红细胞增多症1例,女性,47岁。(二)诊断依据
The hospital in early 1973 ~ early 1975, two years of application of the Guangdong Provincial Institute of Pharmaceutical Industry provided hydroxyurea co-treatment of leukemia in 26 cases of polycythemia vera in 1 case. Now the treatment results are as follows. First, materials and methods (a) cases (all inpatient cases) 1. Chronic granulocytic leukemia (CML) in 11 cases, 6 females, 5 males; aged 19 to 56 years old in 10 cases, 1 year old in 1 case. Belongs to the initial diagnosis, the first to receive anti-leukemia drug treatment in 4 cases, the remaining 7 cases were treated with Maryland or other anti-leukemia drug treatment. 2. Acute chronic myelogenous leukemia (CML acute abscess) in 6 cases, 1 female, 5 males, aged 15 to 46 years, each case were repeatedly treated with Maryland. 3 acute myeloid leukemia (acute particles) in 4 cases, 1 female, male 3 cases, aged 19 to 22 years. 4 acute monocytic leukemia (urgent orders) 3 cases, all men, aged 26 to 49 years old. 5 cases of acute lymphoblastic leukemia (acute lymphoblastic) in 2 cases, 1 male and 1 female, aged 23 and 47 respectively. 6. Polycythemia vera in 1 case, female, 47 years old. (B) diagnosis based on